Experimental vaccine developed at Oxford University will be tested on humans • British Health Secretary: "We saw promising results" • Objective: One million vaccines by September

• Oxford vaccine developed for corona virus // Photo: Reuters

British health secretary Matt Hancock announced today that an experimental vaccine for coronary disease will be passed on human trials as early as Thursday after clinical trials have shown "promising results."

The vaccine, a development of the Jenner Institute at the University of Oxford, will be coming into serial production in the coming days, with the goal of reaching a large number of vaccines by September, in hopes that the trials will see positive results and the vaccine can be used.

Hancock announced that the British government had transferred £ 20 million to the development team, with the aim of generating a large amount of vaccines. "Vaccine development is uncertain science, but the two development teams working on finding a vaccine have shown promising progress. At the same time, we are increasing vaccine production capacity to bring an effective vaccine to the public in the fastest possible time," Hancock said.

More on:

Will there be a vaccine for Corona by September?

Is the vaccine for Corona found in the camel virus gecko humans?

USA: Corona vaccine will undergo clinical trials

The vaccine developed in Oxford, ChAdOx1 nCoV-19, develops a harmless virus of genetically engineered chimpanzees to mimic certain features of the corona virus. The development team claims to have revealed over eighty percent of efficiency.

Meanwhile, the death toll from the Corona virus in Britain rose again today after three days of relative decline. 828 people die from the passing corona virus in hospitals across the UK, raising the total death toll in the kingdom to 17,337. The overall infection rate in the country is 129,000.